Implantable Marker Recall: Hologic Removes BioZorb 3D Bioabsorbable Markers due to Risk for Patient Complications
BioZorb Markers are implantable and used to mark soft tissue for procedures. They are being recalled...
Publisher
USA
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- FDA MedWatch
- Region
- USA
- Scope
- Regulatory
- Published
- June 30, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
BioZorb Markers are implantable and used to mark soft tissue for procedures. They are being recalled...
Source route
Continue on fda.gov
Leave the platform to read the original full article on the publisher site.
Source: FDA MedWatch
Scope: Regulatory
Related coverage
More related coverage
National Chlamydia Screening Programme (NCSP): incident reporting policy
Policy to report incidents during delivery of chlamydia screening to the UK Health Security Agency (...
MRSA, MSSA, Gram-negative bacteraemia and CDI: monthly data, 2025 to 2026
MRSA, MSSA, Gram-negative bacteraemia infections by organisation and location of onset, and Clostrid...
RSV vaccination: expansion of eligibility to older adults in certain clinical risk groups
Information on the expansion of the eligibility criteria of the older adults respiratory syncytial v...
Pre-release access list: monthly HCAI statistical release
List of those receiving pre-release access to the monthly UK Health Security Agency mandatory health...